Delivery Order 36F79724D0159-15B50926F00000098
Award Date 7/1/26
Potential Completion Date 7/31/26
Potential Value $62K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Titusville, Hopewell Township, NJ 08560, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Federal Correctional Institution Fort Worth awarded a delivery order valued at approximately $62K to Actelion Pharmaceuticals US, Inc. for pharmaceutical products Uptravi (selexipag) and Opsumit through a Firm Fixed Price contract with a completion date of May 31, 2026. This delivery order is a child contract issued under the parent Federal Supply Schedule 61-IB (Pharmaceuticals and Drugs) contract, which provides a streamlined procurement vehicle for federal agencies to order pre-negotiated...
- The Federal Correctional Institution Fort Worth awarded a delivery order valued at $61,988.37 to Actelion Pharmaceuticals US, Inc. for pharmaceutical supplies under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). This firm fixed-price delivery order, issued on September 1, 2026, with a completion date of September 30, 2026, procures Uptravi and Opsumit—specialized medications used to treat pulmonary arterial hypertension and related rare diseases. The order carries no small...
- Actelion Pharmaceuticals US, Inc. has been awarded a delivery order valued at approximately $62k by the Federal Correctional Institution Fort Worth for the supply of Uptravi (selexipag) and Opsumit pharmaceutical products, with a completion date of June 30, 2026. This award is a firm fixed-price delivery order issued without a set-aside designation and represents part of the company's ongoing pharmaceutical supply relationship with the Federal Bureau of Prisons. The products will be delivered to...
- The Federal Correctional Institution Fort Worth awarded a delivery order to Actelion Pharmaceuticals US, Inc. on April 1, 2026, with a ceiling value of $61,988.37 and completion date of April 30, 2026. This firm fixed-price delivery order falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, a multiple-award schedule valued at $219.1 million with a performance period extending through July 31, 2029. The award carries no set-aside designation, and the ordering is...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a $215,044.95 delivery order to Actelion Pharmaceuticals US, Inc. for the provision of medication for inmate use. This order was placed against Actelion's Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs, which allows federal agencies to procure needed prescription medications at pre-negotiated pricing. Actelion Pharmaceuticals is a for-profit organization that manufactures...
- Actelion Pharmaceuticals US, Inc. has been awarded a $19,535.58 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the General Services Administration. The order is for 1,600 microgram bottles of Uptravi to be provided to the Federal Bureau of Prisons' Federal Medical Center in Carswell, Texas by February 2029. The delivery order was issued without a set-aside designation by the Department of Justice Bureau of Prisons on February 2, 2024. Actelion...
- Actelion Pharmaceuticals US, Inc. has been awarded a firm fixed-price delivery order valued at $12.5M by the Federal Medical Center Carswell for an emergency procurement of Opsumit 10mg (quantity 2 at $6,270.03 each), with an ultimate completion date of December 3, 2025. This delivery order was issued without a small business set-aside designation and represents direct pharmaceutical procurement under the company's existing Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and...
- This federal contract award, valued at $72,516.33, was issued by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Actelion Pharmaceuticals US, Inc., a large for-profit pharmaceutical manufacturer. The contract is a delivery order under Actelion's existing Federal Supply Schedule (FSS-61-IB) contract with the Department of Veterans Affairs (VA), which has a total potential value of $219,108,390 over the period of August 2024 to July 2029. The contract provides for...
- Actelion Pharmaceuticals US, Inc. has been awarded a $19,535.58 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the General Services Administration. The order is for 1,600 microgram bottles of Uptravi to be provided to the Federal Bureau of Prisons' Federal Medical Center in Carswell, Texas by February 2029. No set-aside designation was used for this award placed under the prime contractor's existing $105 million, five-year Pharmaceuticals...
- Actelion Pharmaceuticals US, Inc. has been awarded a firm fixed-price delivery order valued at $12,540.06 for the procurement of Opsumit 10mg (2 units at $6,270.03 each) in December 2025. The award was made by the Federal Medical Center Carswell, a civilian healthcare facility, with the product to be delivered to Titusville, Hopewell Township, New Jersey. This delivery order carries no small business set-aside designation and represents a direct pharmaceutical procurement under the...